These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6127455)

  • 1. The clinical use of antipsychotic medications.
    Coyle JT
    Med Clin North Am; 1982 Sep; 66(5):993-1009. PubMed ID: 6127455
    [No Abstract]   [Full Text] [Related]  

  • 2. ASHP therapeutic position statement on the use of second-generation antipsychotic medications in the treatment of adults with psychotic disorders.
    Noel JM;
    Am J Health Syst Pharm; 2007 Apr; 64(8):863-76. PubMed ID: 17420192
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathophysiology of antipsychotic drug-induced movement disorders.
    Casey DE
    J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenomenological differences between spontaneous and drug-related extrapyramidal syndromes in patients with schizophrenia-spectrum disorders.
    Peralta V; de Jalón EG; Campos MS; Cuesta MJ
    J Clin Psychopharmacol; 2013 Jun; 33(3):438-40. PubMed ID: 23609391
    [No Abstract]   [Full Text] [Related]  

  • 5. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models.
    Casey DE
    Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of second-generation antipsychotics in the treatment of psychotic disorders.
    Jackson CW
    Am J Health Syst Pharm; 2007 Apr; 64(8):815. PubMed ID: 17420195
    [No Abstract]   [Full Text] [Related]  

  • 8. Extrapyramidal motor abnormalities associated with late-life psychosis.
    Caligiuri MP; Lohr JB; Panton D; Harris MJ
    Schizophr Bull; 1993; 19(4):747-54. PubMed ID: 7905662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinematic analysis of handwriting movements in schizophrenic patients.
    Gallucci RM; Phillips JG; Bradshaw JL; Vaddadi KS; Pantelis C
    Biol Psychiatry; 1997 Apr; 41(7):830-3. PubMed ID: 9084903
    [No Abstract]   [Full Text] [Related]  

  • 10. [Occurrence of tardive extrapyramidal symptoms in schizophrenic patients undergoing prolonged neuroleptic treatment].
    Rybakowski J; Jaracz J; Lis B; Milewska G; Lezańska M
    Psychiatr Pol; 1979; 13(5):479-85. PubMed ID: 42096
    [No Abstract]   [Full Text] [Related]  

  • 11. Tardive dyskinesia: preclinical and clinical aspects.
    Gattaz WF; Gerlach J
    Eur Arch Psychiatry Clin Neurosci; 1993; 243(2):116-8. PubMed ID: 8105897
    [No Abstract]   [Full Text] [Related]  

  • 12. Tardive dyskinesia circa 2006.
    Kane JM
    Am J Psychiatry; 2006 Aug; 163(8):1316-8. PubMed ID: 16877639
    [No Abstract]   [Full Text] [Related]  

  • 13. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research.
    Kerwin RW
    Br J Psychiatry; 1994 Feb; 164(2):141-8. PubMed ID: 7513599
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipsychotic drugs: clinical pharmacology and therapeutic use.
    Davis JM; Casper R
    Drugs; 1977 Oct; 14(4):260-82. PubMed ID: 21069
    [No Abstract]   [Full Text] [Related]  

  • 16. The efficacy, safety, and tolerability of antipsychotics in the elderly.
    Maixner SM; Mellow AM; Tandon R
    J Clin Psychiatry; 1999; 60 Suppl 8():29-41. PubMed ID: 10335669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    Honer WG; Kopala LC; Rabinowitz J
    J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosis in elderly patients: classification and pharmacotherapy.
    Mintzer J; Targum SD
    J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):199-206. PubMed ID: 14653427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side effect profiles of new antipsychotic agents.
    Casey DE
    J Clin Psychiatry; 1996; 57 Suppl 11():40-5; discussion 46-52. PubMed ID: 8941170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine: more side effects but still the best antipsychotic.
    Kang X; Simpson GM
    J Clin Psychiatry; 2010 Aug; 71(8):982-3. PubMed ID: 20797378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.